Business UpdateJul 9, 2026, 08:18 AM
POMDOCTOR Advances AI-Enabled Chronic Disease Management Strategy
AI Summary
POMDOCTOR Limited highlighted its ongoing efforts to build an AI-powered chronic disease management ecosystem. The company is integrating artificial intelligence, remote patient monitoring, wearable technologies, and real-world healthcare data to evolve into a predictive, continuous, and personalized healthcare service provider. This strategy aligns with market trends, as the global AI chronic disease prevention market is projected to grow significantly from $30.2 billion in 2026 to $488.4 billion by 2035.
Key Highlights
- POMDOCTOR is advancing its AI-enabled chronic disease management strategy.
- The company integrates AI, remote patient monitoring, wearables, and real-world data.
- Global AI chronic disease prevention market is projected to reach $488.4 billion by 2035.
- This market is expected to grow at a CAGR of 36.2% from $30.2 billion in 2026.
- Global chronic disease management technology market to grow from $7.21 billion (2025) to $15.01 billion (2033).
- The company aims to transition from reactive treatment to predictive, personalized healthcare.
Price Impact
More from POM